CIK 0001477449 · Large accelerated filer
Teladoc Health, Inc.
Sign in to watch- Ticker
- TDOC
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043705970
- Phone
- 2036352002
- Business address
- 155 E 44TH STREET, SUITE 1700, NEW YORK, NY, 10017
- Former names
- Teladoc, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $731,651
- in 9 filings, $369K under 10b5-1 plans
Net −$731,651. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Nueno Carlos −$310K President, International sold 50% of stake
- DIVITA CHARLES III −$224K CHIEF EXECUTIVE OFFICER sold 7% of stake
- Rodrigues Fernando M. −$98K President of BetterHelp sold 100% of stake
- Vandervoort Adam C −$48K CHIEF LEGAL OFFICER, SECRETARY sold 6% of stake
- Bliss Kelly −$46K President, U.S. Group Health sold 7% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-05-07 | SNOW DAVID B JR Director | Gift | −52,000 | 47,332 | ||
| 2021-05-07 | SNOW DAVID B JR Director | Gift | +52,000 | 52,000 | ||
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −1,300 | $154.12 | $200K | 484,670 |
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −1,000 | $155.06 | $155K | 483,670 |
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −2,400 | $156.24 | $375K | 481,270 |
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −3,853 | $156.95 | $605K | 477,417 |
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −1,047 | $158.30 | $166K | 476,370 |
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −300 | $159.52 | $48K | 476,070 |
| 2021-05-04 | GOREVIC JASON N Chief Executive Officer | Sale | −100 | $160.50 | $16K | 475,970 |
| 2021-05-03 | Jensen Claus Torp Chief Innovation Officer | Grant or award · Employee Stock Option (right to buy) | +6,796 | 6,796 | ||
| 2021-05-03 | Jensen Claus Torp Chief Innovation Officer | Grant or award · Restricted Stock Units | +16,849 | 16,849 | ||
| 2021-04-19 | Taneja Hemant Director | Sale | −1,200 | $181.71 | $218K | 142,560 |
| 2021-04-19 | Taneja Hemant Director | Sale | −8,266 | $182.67 | $1.5M | 134,294 |
| 2021-04-19 | Taneja Hemant Director | Sale | −3,000 | $183.43 | $550K | 131,294 |
| 2021-04-19 | Taneja Hemant Director | Sale | −1,900 | $184.58 | $351K | 129,394 |
| 2021-04-19 | Taneja Hemant Director | Sale | −900 | $185.69 | $167K | 128,494 |
| 2021-04-19 | Taneja Hemant Director | Sale | −1,100 | $186.78 | $205K | 127,394 |
| 2021-04-19 | Taneja Hemant Director | Sale | −1,934 | $188.01 | $364K | 125,460 |
| 2021-04-19 | Taneja Hemant Director | Sale | −2,122 | $189.09 | $401K | 123,338 |
| 2021-04-19 | Taneja Hemant Director | Sale | −4,278 | $189.80 | $812K | 119,060 |
Page 72 of 74 · 1,476 trades